Targeting NF-κB in Hepatic Ischemia-Reperfusion Alleviation: from Signaling Networks to Therapeutic Targeting

摘要

Hepatic ischemia-reperfusion injury (HIRI) is a major complication of liver trauma, resection, and transplantation that can lead to liver dysfunction and failure. Scholars have proposed a variety of liver protection methods aimed at reducing ischemia-reperfusion damage, but there is still a lack of effective treatment methods, which urgently needs to find new effective treatment methods for patients. Many studies have reported that signaling pathway plays a key role in HIRI pathological process and liver function recovery mechanism, among which nuclear transfer factor-kappa B (NF-kappa B) signaling pathway is one of the signal transduction closely related to disease. NF-kappa B pathway is closely related to HIRI pathologic process, and inhibition of this pathway can delay oxidative stress, inflammatory response, cell death, and mitochondrial dysfunction. In addition, NF-kappa B can also interact with PI3K/Akt, MAPK, and Nrf2 signaling pathways to participate in HIRI regulation. Based on the role of NF-kappa B pathway in HIRI, it may be a potential target pathway for HIRI. This review emphasizes the role of inhibiting the NF-kappa B signaling pathway in oxidative stress, inflammatory response, cell death, and mitochondrial dysfunction in HIRI, as well as the effects of related drugs or inhibitors targeting NF-kappa B on HIRI. The objective of this review is to elucidate the role and mechanism of NF-kappa B pathway in HIRI, emphasize the important role of NF-kappa B pathway in the prevention and treatment of HIRI, and provide a theoretical basis for the target NF-kappa B pathway as a therapy for HIRI.

关键词